The drug maker said that in March it would begin two more clinical trials of remdesivir, an experimental antiviral drug, in more nations outside China.
from Health https://ift.tt/2HYRopR
February 27, 2020
Rose
Health, Health - The New York Times
No comments
Related Posts:
Covid-19 Tests Are in Short Supply. Should You Still Get One?Public health officials once suggested only people with symptoms should be tested. Now some say getting one is a civic duty. from Health https://ift.tt/3k1M46G … Read More
Is Telemedicine Here to Stay?The answer largely depends on whether Medicare and private health insurers will adequately cover virtual doctor visits once coronavirus outbreaks subside. from Health https://ift.tt/33jSbxj … Read More
Scientists Worry About Political Influence Over Coronavirus Vaccine ProjectOperation Warp Speed has moved along at a rapid clip. But some people involved in the process fear pressure to deliver an October surprise for President Trump. from Health https://ift.tt/39MKFwk … Read More
Coronavirus Live Updates: As Cases Surge, U.S. Officials Are at an Impasse Over AidFlorida faces hurricane season. The virus is picking up speed in the Midwest, and in other states that thought they had already seen the worst of it. India’s home minister tests positive. from Health https://ift.tt/3k2A2Ks … Read More
Sanofi and GlaxoSmithKline Snag Biggest Coronavirus Vaccine Deal YetThe arrangement brings the Trump administration’s investment in coronavirus vaccine projects to more than $8 billion. The head of the federal effort is a former GSK executive. from Health https://ift.tt/2XfFeku … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment